Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA: Rare Drugs Could Soon See More Expedited Approvals

The head of the Center for Biologics Evaluation and Research is looking to expand rare disease drug approvals.

Screen Shot 2022 04 18 At 2 43 12 Pm
Getty Images

According to a recent FierceBiotech article, the FDA's Center for Biologics Evaluation and Research director, Peter Marks, revealed that the agency is considering ways to expand accelerated approvals for drugs targeting rare diseases. Marks stated that the FDA now has a better understanding of the data needed to grant accelerated approvals, allowing more drugs to potentially receive quicker authorization. Accelerated approvals rely on surrogate endpoints or biomarkers, which can predict clinical benefit more easily than traditional clinical endpoints. 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report